Despite a preliminary theory that health insurers could potentially hold too much buyer power, resulting in a loss of quality of consulting and preventative care for consumers, the Competition Commission has expressed support of health insurers in its most recent update of a widespread probe into the UK’s private healthcare sector. A common complaint, according to reports, often involves Bupa, one of the UK’s largest private medical insurers; the CC has received complaints that the insurer’s fee schedule reduces consultation quality and hinders innovation. The Commission has said it has “not seen evidence” of these claims, however. While its update did not come down hard on insurers, the Commission did suggest that there may be cause for concern within the private hospital operators’ sector.
Featured News
American Express Loses Appeal Seeking Arbitration of Merchants’ Antitrust Claims
Aug 20, 2026 by
CPI
Portugal Rail Market Faces Competition Push as Regulator Targets Barriers
Aug 20, 2026 by
CPI
France Fines Boohoo €2.3 Million as Scrutiny of Fast-Fashion Pricing Intensifies
Aug 20, 2026 by
CPI
California AG Seeks Structural Fixes in Paramount-Warner Antitrust Fight
Aug 20, 2026 by
CPI
Australia Targets Big Tech With New Levy to Fund Local News
Aug 20, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes